The Inaugural Victor J. Hruby Symposium

Celebrating a Pioneer in Peptide Science

May 21–22, 2026
Health Sciences Innovation Building (HSIB) Forum
University of Arizona College of Medicine – Tucson

Honoring a Global Leader in Peptide Discovery

For more than 50 years, Dr. Victor J. Hruby, Regents’ Professor Emeritus at the University of Arizona and Founding President of the American Peptide Society, has helped shape the field of peptide chemistry, biology, and drug design.

His research has led to groundbreaking receptor-specific agonists and antagonists targeting melanocortin receptors (MC1R and MC4R) and contributed to FDA-approved therapeutics, including:

• Scenesse® (afamelanotide)
• Vyleesi® (bremelanotide)
• Imcivree® (setmelanotide)

Beyond his scientific achievements, Dr. Hruby has mentored generations of researchers and built a global peptide community that continues to innovate and collaborate across academia and industry. This inaugural symposium celebrates both his scientific legacy and the future of peptide therapeutics.

What to Expect

• 1½ days of scientific exchange and collaboration
• Leaders from academia and industry
• Emerging research in peptide drug discovery
• Networking with the global peptide community

Be Part of the Legacy

In conjunction with the symposium, we are launching efforts to establish the:

Hruby Institute for the Study of Peptides

The Institute will advance:

• Innovative peptide research
• Translational drug development
• Cross-disciplinary collaboration
• Training of the next generation of scientists

Your support helps ensure that Dr. Hruby’s vision continues to drive discovery and therapeutic innovation for decades to come.

Sponsorship Opportunities are also available. 

Sponsors receive prominent recognition in symposium materials, on the website, and during the event. 

SPONSORS REGISTER HERE

Join us as an attendee, speaker, or sponsor — and help shape the future of peptide science.

For more information, visit the official symposium website: victorhruby.com.